Frontiers in Public Health · 2024 · 11 citations · 35 references
MedicineGeneticsPharmacogeneticsPharmacogenomicsPrecision MedicineClinical Implementation Of PharmacogeneticsClinical Implementation Of PharmacogenomicsClinical TrialsPharmacogenetic TestingPharmacogenomic Data InterpretationPharmacogenomic TestingEthical Considerations In ScreeningGenetic InterpretationGenetic Testing InterpretationHealthcare Provider EducationIntegration Of Pharmacogenomic Results Into Care PlansPersonalized Medicine ImplementationPrecision Medicine EthicsResearch Investment
Pharmacogenomics (PGx) is an important component of precision medicine that promises tailored treatment approaches based on an individual's genetic information. Exploring the initiatives in research that help to integrate PGx test into clinical setting, identifying the potential barriers and challenges as well as planning the future directions, are all important for fruitful PGx implementation in any population. Qatar serves as an exemplar case study for the Middle East, having a small native population compared to a diverse immigrant population, advanced healthcare system, national genome program, and several educational initiatives on PGx and precision medicine. This paper attempts to outline the current state of PGx research and implementation in Qatar within the global context, emphasizing ongoing initiatives and educational efforts. The inclusion of PGx in university curricula and healthcare provider training, alongside precision medicine conferences, showcase Qatar's commitment to advancing this field. However, challenges persist, including the requirement for population specific implementation strategies, complex genetic data interpretation, lack of standardization, and limited awareness. The review suggests policy development for future directions in continued research investment, conducting clinical trials for the feasibility of PGx implementation, ethical considerations, technological advancements, and global collaborations to overcome these barriers.
35
Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text
The GenomeAsia 100K Project enables genetic discoveries across Asia
Jeffrey D. Wall, Eric Stawiski, Aakrosh Ratan et al. · Nature · 2019 · 479 citations · Full text
Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease
Wei Zhou, Masahiro Kanai, Kuan-Han Wu et al. · Cell Genomics · 2022 · 407 citations · Full text
Felix W. Frueh, Shashi Amur, Padmaja Mummaneni et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2008 · 306 citations